Form 8-K - Current report:
SEC Accession No. 0000950170-22-000156
Filing Date
2022-01-10
Accepted
2022-01-10 06:06:06
Documents
14
Period of Report
2022-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxst-20220109.htm   iXBRL 8-K 53972
2 EX-99.1 rxst-ex99_1.htm EX-99.1 22075
3 GRAPHIC img261313502_0.jpg GRAPHIC 4493
  Complete submission text file 0000950170-22-000156.txt   203716

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxst-20220109_pre.xml EX-101.PRE 9926
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxst-20220109.xsd EX-101.SCH 2480
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxst-20220109_lab.xml EX-101.LAB 13438
8 EXTRACTED XBRL INSTANCE DOCUMENT rxst-20220109_htm.xml XML 4688
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Filer) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40690 | Film No.: 22519535
SIC: 3851 Ophthalmic Goods